Trademark: 97485013
Status Date
Thursday, January 11, 2024
Filing Date
Friday, July 1, 2022
5 pharmaceutical preparations for the treatment of epilepsy, essential tremors, Parkinson's disease, epileptiform disorders, Huntington's disease, Alzheimer's, dementia, GABA hypofunction, and NMDA hypofunction; pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression
Jan 11, 2024
Report Completed Suspension Check Case Still Suspended
Jul 14, 2023
Notification Of Letter Of Suspension E-Mailed
Jul 14, 2023
Letter Of Suspension E-Mailed
Jul 14, 2023
Suspension Letter Written
Jul 7, 2023
Teas/Email Correspondence Entered
Jul 7, 2023
Correspondence Received In Law Office
Jul 7, 2023
Teas Response To Office Action Received
Apr 5, 2023
Application Extension Granted/Receipt Provided
Apr 5, 2023
Application Extension To Response Period - Received
Jan 10, 2023
Notification Of Non-Final Action E-Mailed
Jan 10, 2023
Non-Final Action E-Mailed
Jan 10, 2023
Non-Final Action Written
Jan 3, 2023
Assigned To Examiner
Jul 21, 2022
New Application Office Supplied Data Entered
Jul 5, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
